Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Farmers Insurance
Daiichi Sankyo
Medtronic
Chubb
Julphar
US Department of Justice
Mallinckrodt
Argus Health
Boehringer Ingelheim

Generated: May 20, 2018

DrugPatentWatch Database Preview

MIRALUMA Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

When do Miraluma patents expire, and when can generic versions of Miraluma launch?

Miraluma is a drug marketed by Lantheus Medcl and is included in one NDA.

The generic ingredient in MIRALUMA is technetium tc-99m sestamibi kit. There are four drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the technetium tc-99m sestamibi kit profile page.
Summary for MIRALUMA
Drug patent expirations by year for MIRALUMA

US Patents and Regulatory Information for MIRALUMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

Expired US Patents for MIRALUMA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Lantheus Medcl MIRALUMA technetium tc-99m sestamibi kit INJECTABLE;INJECTION 019785-003 May 23, 1997 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Baxter
Healthtrust
Julphar
Daiichi Sankyo
Cerilliant
Merck
Teva
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.